Elekta gets OK for treatment planning system for Leksell Gamma Knife Perfexion

By E. Janene Geiss

Philadelphia, July 13 - Elekta said Thursday that the Food and Drug Administration recently approved the 510(k) pre-market clearance for Leksell GammaPlan PFX, the treatment planning system developed for Leksell Gamma Knife Perfexion.

By the ongoing market introduction of Leksell Gamma Knife Perfexion, Elekta said it expands the Leksell Gamma Knife product line with a new system that takes stereotactic radiosurgery to the next level and provides a radiosurgical platform for further refinement and expansion of procedures in the brain, cervical spine and head and neck regions, according to a company news release.

Elekta is a Stockholm, Sweden, medical technology group that provides services for cancer and brain disorders.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.